163 related articles for article (PubMed ID: 24519206)
1. Effect of candesartan on the expression of sclera-choroidal intercellular adhesion molecule-1 in hypercholesterolemic models.
Torres RJ; Luchini A; Torres Rdo R; Oliveira LR; Torres CL; Torres RA; Olandoski M; Nagashima S; Noronha Ld; Precoma DB
Clinics (Sao Paulo); 2014 Feb; 69(2):145-9. PubMed ID: 24519206
[TBL] [Abstract][Full Text] [Related]
2. Effect of olmesartan on leukocyte recruitment in choroid-sclera complex in hypercholesterolemia model.
Torres RJ; de Noronha L; Casella AM; Grobe SF; Martins Ide C; Torres Rdo R; Luchini A; Sturzeneker MC; Torres CL; Precoma DB
J Ocul Pharmacol Ther; 2013 Oct; 29(8):709-14. PubMed ID: 23683100
[TBL] [Abstract][Full Text] [Related]
3. Olmesartan severely weakened the development of NASH in an animal model of hypercholesterolemia.
Sturzeneker MC; Ioshii SO; Villela Baroncini LA; Précoma DB
Atherosclerosis; 2011 May; 216(1):97-102. PubMed ID: 21338989
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of choroid and sclera early alterations in hypercholesterolemic rabbits: histologic and histomorphometric study].
Torres RJ; Maia M; Noronha L; Farah ME; Luchini A; Brik D; Muccioli C; Précoma DB
Arq Bras Oftalmol; 2009; 72(1):68-74. PubMed ID: 19347126
[TBL] [Abstract][Full Text] [Related]
5. [Increased VEGFR-1 immunoreactivity in the choroid-scleral complex in hypercholesterolemia experimental model].
Torres RJ; Noronha Ld; Casella AM; Torres Rdo R; Martins Ide C; Zotz R; Luchini A; Hoffmann Filho CR; Précoma DB
Arq Bras Oftalmol; 2013; 76(1):1-5. PubMed ID: 23812517
[TBL] [Abstract][Full Text] [Related]
6. Expression of TNF-α and IL-6 cytokines in the choroid and sclera of hypercholesterolemic rabbits.
Torres RJ; Luchini A; Barberini LY; Precoma L; Torres CL; Torres RA; Noronha Ld; Erbano BO; Casella AM; Precoma DB
Arq Bras Oftalmol; 2014; 77(3):168-72. PubMed ID: 25295904
[TBL] [Abstract][Full Text] [Related]
7. Effect of flaxseed on choroid-sclera complex thickness and on LDL oxidation in the sclera, choroid and retina of diet-induced hypercholesterolaemic rabbits.
Torres RJ; Luchini A; Both AS; Precoma LB; Champoski AF; Schuh ML; Torres RP; Noronha L; Pessoa BM; Torres LA; Serci NF; Precoma DB
Br J Nutr; 2014 Nov; 112(9):1438-46. PubMed ID: 25247699
[TBL] [Abstract][Full Text] [Related]
8. [Increase of choroidal and scleral MCP-1 expression in hypercholesterolemia experimental model].
Torres RJ; Noronha Ld; Casella AM; Lumikoski TI; Précoma LB; Torres CL; Luchini A; Sturzeneker MC; Précoma DB
Arq Bras Oftalmol; 2012; 75(1):48-52. PubMed ID: 22552418
[TBL] [Abstract][Full Text] [Related]
9. Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus.
Rosei EA; Rizzoni D; Muiesan ML; Sleiman I; Salvetti M; Monteduro C; Porteri E;
J Hypertens; 2005 Feb; 23(2):435-44. PubMed ID: 15662233
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin receptor blockade with candesartan attenuates atherosclerosis, plaque disruption, and macrophage accumulation within the plaque in a rabbit model.
Johnstone MT; Perez AS; Nasser I; Stewart R; Vaidya A; Al Ammary F; Schmidt B; Horowitz G; Dolgoff J; Hamilton J; Quist WC
Circulation; 2004 Oct; 110(14):2060-5. PubMed ID: 15451796
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 1 receptor blockers suppress neointimal hyperplasia after stent implantation in carotid arteries of hypercholesterolemic rabbits.
Ichikawa N; Toma N; Kawakita F; Matsushima S; Imanaka-Yoshida K; Yoshida T; Taki W; Suzuki HI
Neurol Res; 2015 Feb; 37(2):147-52. PubMed ID: 25089806
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of rupture of atherosclerotic plaque by Candesartan in rabbit model].
Zhou XF; Yin HC; Zhu WL; Shen L; Yu T; Li SA; Meng ZM; Wu AS; Qian HD
Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):106-11. PubMed ID: 20388376
[TBL] [Abstract][Full Text] [Related]
13. Vitamin E supplementation suppresses macrophage accumulation and endothelial cell expression of adhesion molecules in the aorta of hypercholesterolemic rabbits.
Koga T; Kwan P; Zubik L; Ameho C; Smith D; Meydani M
Atherosclerosis; 2004 Oct; 176(2):265-72. PubMed ID: 15380448
[TBL] [Abstract][Full Text] [Related]
14. Role of NF-κβ and oxidative pathways in atherosclerosis: cross-talk between dyslipidemia and candesartan.
Hadi NR; Yousif NG; Abdulzahra MS; Mohammad BI; Al-Amran FG; Majeed ML; Yousif MG
Cardiovasc Ther; 2013 Dec; 31(6):381-7. PubMed ID: 23566285
[TBL] [Abstract][Full Text] [Related]
15. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
[TBL] [Abstract][Full Text] [Related]
16. Naringin has an antiatherogenic effect with the inhibition of intercellular adhesion molecule-1 in hypercholesterolemic rabbits.
Choe SC; Kim HS; Jeong TS; Bok SH; Park YB
J Cardiovasc Pharmacol; 2001 Dec; 38(6):947-55. PubMed ID: 11707699
[TBL] [Abstract][Full Text] [Related]
17. Protection against oxidative stress in diabetic rats: role of angiotensin AT(1) receptor and beta 1-adrenoceptor antagonism.
Dorenkamp M; Riad A; Stiehl S; Spillmann F; Westermann D; Du J; Pauschinger M; Noutsias M; Adams V; Schultheiss HP; Tschöpe C
Eur J Pharmacol; 2005 Sep; 520(1-3):179-87. PubMed ID: 16139267
[TBL] [Abstract][Full Text] [Related]
18. Candesartan, angiotensin II type 1 receptor blocker is able to relieve age-related cognitive impairment.
Trofimiuk E; Wielgat P; Braszko JJ
Pharmacol Rep; 2018 Feb; 70(1):87-92. PubMed ID: 29331792
[TBL] [Abstract][Full Text] [Related]
19. The effect of statins on angiotensin II-induced hemodynamic changes in young, mildly hypercholesterolemic men.
Fleischmann EH; John S; Delles C; Schneider MP; Schmidt BM; Schmieder RE
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1120-6. PubMed ID: 15607618
[TBL] [Abstract][Full Text] [Related]
20. Changes in morphology and optical properties of sclera and choroidal layers due to hyperosmotic agent.
Zaman RT; Rajaram N; Nichols BS; Rylander HG; Wang T; Tunnell JW; Welch AJ
J Biomed Opt; 2011 Jul; 16(7):077008. PubMed ID: 21806288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
